These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 38388259)

  • 1. Structured Weaning From the Impella Left Ventricular Micro-Axial Pump in Acute Myocardial Infarction With Cardiogenic Shock and Protected Percutaneous Coronary Intervention: Experience From a Non-Cardiac Surgical Centre.
    Slack RJ; McGain F; Cox N; French C; Cheng V; Stub D; Zakhem B; Dade F; Bloom JE; Chan W; Yang Y
    Heart Lung Circ; 2024 Apr; 33(4):460-469. PubMed ID: 38388259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term survival after early unloading with Impella CP
    Loehn T; O'Neill WW; Lange B; Pfluecke C; Schweigler T; Mierke J; Waessnig N; Mahlmann A; Youssef A; Speiser U; Strasser RH; Ibrahim K
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):149-157. PubMed ID: 30456984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock.
    Helgestad OKL; Josiassen J; Hassager C; Jensen LO; Holmvang L; Udesen NLJ; Schmidt H; Berg Ravn H; Moller JE
    Open Heart; 2020; 7(1):e001214. PubMed ID: 32201591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Impella Support in Postcardiac Arrest Cardiogenic Shock Complicating Acute Myocardial Infarction Improves Short- and Long-Term Survival.
    Chatzis G; Markus B; Luesebrink U; Ahrens H; Divchev D; Syntila S; Scheele N; Al Eryani H; Tousoulis D; Schieffer B; Karatolios K
    Crit Care Med; 2021 Jun; 49(6):943-955. PubMed ID: 33729726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impella 2.5 initiated prior to unprotected left main PCI in acute myocardial infarction complicated by cardiogenic shock improves early survival.
    Meraj PM; Doshi R; Schreiber T; Maini B; O'Neill WW
    J Interv Cardiol; 2017 Jun; 30(3):256-263. PubMed ID: 28419573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes among cardiogenic shock patients supported with high-capacity Impella axial flow pumps: A report from the Cardiogenic Shock Working Group.
    Fried J; Farr M; Kanwar M; Uriel N; Hernandez-Montfort J; Blumer V; Li S; Sinha SS; Garan AR; Li B; Hall S; Hickey GW; Mahr C; Nathan S; Schwartzman A; Kim J; Ton VK; Vishnevsky OA; Vorovich E; Abraham J; Zweck E; Guglin M; Vallabhajosyula S; Kataria R; Walec KD; Zazzali P; Kong Q; Sangal P; Burkhoff D; Kapur NK
    J Heart Lung Transplant; 2024 Sep; 43(9):1478-1488. PubMed ID: 38834162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience.
    Ouweneel DM; de Brabander J; Karami M; Sjauw KD; Engström AE; Vis MM; Wykrzykowska JJ; Beijk MA; Koch KT; Baan J; de Winter RJ; Piek JJ; Lagrand WK; Cherpanath TG; Driessen AH; Cocchieri R; de Mol BA; Tijssen JG; Henriques JP
    Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):338-349. PubMed ID: 30403366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group.
    Doshi R; Patel K; Decter D; Jauhar R; Meraj P
    Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S90-S95. PubMed ID: 30122245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up.
    Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F
    J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention.
    Javaid AI; Michalek JE; Gruslova AB; Hoskins SA; Ahsan CH; Feldman MD
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):30-41. PubMed ID: 37997292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of Impella 2.5 use in patients undergoing Percutaneous Coronary Intervention in Henan, China: a case series.
    Bhat RA; Ali SM; Rathi A; Bhat JA; Iqbal RS; Islam MM; Maqbool S; Tibrewal A; Qu Y; Zhang Y; Sun Y; Xiao W; Gao C
    Perfusion; 2023 Jan; 38(1):208-213. PubMed ID: 34581607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device.
    Saito S; Okubo S; Matsuoka T; Hirota S; Yokoyama S; Kanazawa Y; Takei Y; Tezuka M; Tsuchiya G; Konishi T; Shibasaki I; Ogata K; Fukuda H
    J Cardiol; 2024 Apr; 83(4):228-235. PubMed ID: 37926367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock.
    Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P
    Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and outcomes in patients with cardiogenic shock complicating acute myocardial infarction: early vs recent experience with impella.
    Singh H; Mehta RH; O'Neill W; Kapur NK; Lalonde T; Ohman M; Ghiu I; Chen-Hsing Y; Dutcheshen K; Schreiber T; Rosman H; Kaki A
    Am Heart J; 2021 Aug; 238():66-74. PubMed ID: 33848505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical circulatory support with the Impella® LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: The IMPELLA-STIC randomized study.
    Bochaton T; Huot L; Elbaz M; Delmas C; Aissaoui N; Farhat F; Mewton N; Bonnefoy E;
    Arch Cardiovasc Dis; 2020 Apr; 113(4):237-243. PubMed ID: 31740272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device.
    O'Neill WW; Grines C; Schreiber T; Moses J; Maini B; Dixon SR; Ohman EM
    Am Heart J; 2018 Aug; 202():33-38. PubMed ID: 29803984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microaxial circulatory support for percutaneous coronary intervention: A systematic review and meta-analysis.
    Leon SA; Rosen JL; Ahmad D; Austin MA; Vishnevsky A; Rajapreyar IN; Ruggiero NJ; Rame JE; Entwistle JW; Massey HT; Tchantchaleishvili V
    Artif Organs; 2023 Jun; 47(6):934-942. PubMed ID: 36691820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of impella placement in PCI for acute myocardial infarction complicated by cardiogenic shock: An updated meta-analysis.
    Iannaccone M; Franchin L; Hanson ID; Boccuzzi G; Basir MB; Truesdell AG; O'Neill W
    Int J Cardiol; 2022 Sep; 362():47-54. PubMed ID: 35533755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock.
    Jensen PB; Kann SH; Veien KT; Møller-Helgestad OK; Dahl JS; Rud CS; Jensen MK; Jensen LO; Schmidt H; Møller JE
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):53-61. PubMed ID: 29148290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.